25 investors collectively hold a majority stake of 47% in Humacyte, Inc. with individual investors owning 50% and institutions owning 20%. The largest institutional shareholder is Fresenius Medical Care AG with 15% ownership.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing